Skip to main content

As Primate Research Drops in Europe, Overseas Options Appeal

A combination of public opposition, intense regulations, and rising costs in the EU make conditions in China and elsewhere attractive for studying monkeys.

Written byKatarina Zimmer
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00

ABOVE: © ISTOCK, SEREGRAFF

The use of monkeys in European research has been steadily declining. For instance, approximately 6,000 were used in scientific procedures in the European Union (EU) in 2011, compared with nearly 10,000 in 2008—counting both academic and industrial research. Most recently, a UK government report noted the number of primate experiments had fallen for the third consecutive year.

Researchers suspect that a combination of increasing regulatory pressure, rising costs, and mounting disapproval among the public are responsible. Some countries, such as the Netherlands and Belgium, have even taken political measures to deliberately scale back on primate research.

China recognizes that it’s going to be a leader in primate research and I have no doubt that that’s going to be true.

“The consequence of this is [the risk] that a lot of this research will move abroad,” says Stefan Treue, director of the Cognitive Neuroscience Laboratory at the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays